invasive pneumococcal disease in Fiji: Clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine

Fiona Russell, Jonathan Carapetis, Lisi Tikoduadua, Reginald Chandra, Anna Seduadua, Catherine Satzke, Jan Pryor, Eka Buadromo, Lepani Waqatakirewa, Edward (Kim) MULHOLLAND

Research output: Contribution to journalArticlepeer-review

Abstract

Invasive pneumococcal disease (IPD) epidemiology and the potential impact of the pneumococcal conjugate vaccine in Fiji are documented. The annual incidence was 26.5 and 10.9 in those aged <5 and <55 years per 100,000, respectively. The case fatality rate was 9.4% and 67% in <5 and >65 year olds, respectively. One pneumococcal death and case would be prevented in <5 years olds for every 1930 and 128 infants vaccinated with 7vPCV, respectively. � 2010 by Lippincott Williams & Wilkins.
Original languageEnglish
Pages (from-to)870-872
Number of pages3
JournalPediatric Infectious Disease Journal
Volume29
Issue number9
Publication statusPublished - 2010

Fingerprint

Dive into the research topics of 'invasive pneumococcal disease in Fiji: Clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine'. Together they form a unique fingerprint.

Cite this